SEC Filings - Checkmate Pharmaceuticals

Filing date	Form	Description	Filing Group	View
Dec 8, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-20-312717.pdf 0001193125-20-312717.rtf 0001193125-20-312717.xls View HTML
Nov 13, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-20-292254.pdf 0001193125-20-292254.rtf 0001193125-20-292254.xls View HTML
Nov 13, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	0001193125-20-292303.pdf 0001193125-20-292303.rtf 0001193125-20-292303.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Nov 12, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-20-030841.pdf 0000899243-20-030841.rtf 0000899243-20-030841.xls View HTML
Nov 12, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-20-030842.pdf 0000899243-20-030842.rtf 0000899243-20-030842.xls View HTML
Nov 12, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-20-030847.pdf 0000899243-20-030847.rtf 0000899243-20-030847.xls View HTML
Nov 10, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	Other	0001193125-20-290036.pdf 0001193125-20-290036.rtf 0001193125-20-290036.xls View HTML
Oct 20, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-20-272854.pdf 0001193125-20-272854.rtf 0001193125-20-272854.xls View HTML
Oct 6, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	Other	0000905148-20-001079.pdf 0000905148-20-001079.rtf 0000905148-20-001079.xls View HTML
Oct 5, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-20-263315.pdf 0001193125-20-263315.rtf 0001193125-20-263315.xls View HTML

Data provided by Kaleidoscope.